Morphocell Technologies
Phyla Kay, MSc, MBA, is a Project Manager and QA Specialist Senior at Morphocell Technologies. Previously, Phyla worked at PhenoSwitch Bioscience as Business Development and Project Manager and Director of Operations. With a background in Science and Biotechnology, Phyla has experience as a Scientist at Caprion Biosciences Inc. and as a Research Assistant at ImmuneCarta. Phyla's educational background includes a Master of Science in Pharmacology, a Master of Business Administration in Business Administration and Management, and a Bachelor of Science in Biotechnology. Additionally, Phyla holds a Technical Laboratory degree in Biotechnology and is pursuing a Certificate in Pharmaceutical Sciences.
This person is not in any teams
This person is not in any offices
Morphocell Technologies
Morphocell Technologies Inc. is a regenerative medicine company focused on the development and commercialization of stem cell therapies and engineered tissues targeting liver failure. The Company is a spin-off of the Hepatology and Cell Therapy lab of Sainte-Justine University Hospital Center, in Montreal. Founded in April 2018 on the technology developed by Dr.Paganelli, a pediatric transplant hepatologist and stem cell scientist, Morphocell Technologies aims at bringing to market the first effective treatment for acute, chronic and acute-on-chronic liver failure.